April 20, 2011
Novartis AG et al v. Teva Pharmaceuticals USA Inc.
Case Number:
1:11-cv-00353
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 20, 2011
Novartis Targets Teva Over Myfortic Patents
Novartis AG accused Israeli generics maker Teva Pharmaceutical Industries Ltd. in Delaware on Wednesday of infringing a group of its patents related to immunosuppressive agent Myfortic.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login